GSK rises on cost-savings program, Q2 profit beat
BUZZ-GSK rises on cost-savings program, Q2 profit beat
** Shares of British drugmaker GSK GSK.L up 4.2% to near five-month high of 2,046p, among top gainers on FTSE 100 .FTSE
** Co launches a £1.9 billion ($2.52 billion) cost-saving program, expected to be fully realised by 2029
** Reports Q2 revenue of £8.41 billion and core earnings of 50.5 pence per share, ahead of analyst expectations of £8.24 billion and 47.1 pence, respectively, according to company-compiled consensus estimates
** British drugmaker reaffirms its annual forecast for sales growth and core operating profit growth expectations.
** As of last close, GSK up 6.6% YTD
($1 = 0.7532 pounds)
(Reporting by Anushka Chourasia in Bengaluru)